Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1xdk | REA | Retinoic acid receptor beta |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1xdk | REA | Retinoic acid receptor beta | / | 1.000 | |
| 4dm6 | TTB | Retinoic acid receptor beta | / | 0.575 | |
| 4dm8 | REA | Retinoic acid receptor beta | / | 0.573 | |
| 1fd0 | 254 | Retinoic acid receptor gamma | / | 0.542 | |
| 1exa | 394 | Retinoic acid receptor gamma | / | 0.541 | |
| 1fcx | 184 | Retinoic acid receptor gamma | / | 0.535 | |
| 1fcy | 564 | Retinoic acid receptor gamma | / | 0.523 | |
| 2lbd | REA | Retinoic acid receptor gamma | / | 0.502 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.469 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
| 2lf1 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 1s7g | NAD | NAD-dependent protein deacylase 2 | / | 0.450 | |
| 2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.450 | |
| 1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.447 | |
| 2hm9 | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.446 | |
| 2bxo | OPB | Serum albumin | / | 0.443 | |
| 3fmz | 2T1 | Retinol-binding protein 4 | / | 0.442 | |
| 4dk7 | 0KS | Oxysterols receptor LXR-beta | / | 0.442 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.442 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.441 | |
| 2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.440 |